ATIVESITE | Why we have to embrace the incredible complexity of cancer

Cancer is an incredibly complex disease, and as Global Head, Oncology Innovative Targets & Technologies Cory Johannessen explains, to make a difference in patients’ lives we must embrace this complexity.

At Novartis, we’re committed to unraveling the inner workings of cancer and to building as broad and deep a toolbox of approaches as we can. It’s why we we’re working to develop new therapies for a vast range of cancers, both common and rare; why we’re investing in diverse technology platforms and experimenting with combination approaches; why we’re pursuing powerful new tools like artificial intelligence, and much more.

Learn more: https://bit.ly/3fYShD1

©2022 Novartis AG

Source Novartis YouTube